[D,L-kavain in comparison with oxazepam in anxiety disorders. A double-blind study of clinical effectiveness].
In a placebo-controlled double blind clinical trial, 38 out-patients with anxiety associated with neurotic or psychosomatic disturbances were treated with D,L-Kavain (Neuronika) or Oxazepam. The anxiolytic effectiveness of the two preparations was judged by means of the Anxiety Status Inventory (ASI) and the Self-Rating Anxiety Scale (SAS) of Zung. The substances proved to be equivalent in the nature and potency of anxiolytic action. No adverse drug reactions occurred.
Lindenberg
D
D
Psychiatrische Abteilung, Kreiskrankenhaus Tauberbischofsheim.
Pitule-Schödel
H
H
D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010936:Plant Extracts / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D011714:Pyrans / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D010936:Plant Extracts; D011714:Pyrans; D011753:Pyrones; C011889:kavain
D,L-Kavain im Vergleich zu Oxazepam bei Angstzuständen. Doppelblindstudie zur Klinischen Wirksamkeit.